# Mass Balance and Metabolism Study of 14C-Z-215

> **NCT02618629** · PHASE1 · COMPLETED · sponsor: **Zeria Pharmaceutical** · enrollment: 6 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** 14C-Z-215

## Key facts

- **NCT ID:** NCT02618629
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2016-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02618629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02618629, "Mass Balance and Metabolism Study of 14C-Z-215". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02618629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*